Unjha Formulations Ltd.

BSE: 531762

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

23.81-0.1 (-0.33%)

24 Jul, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Unjha Formulations Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR
Total Revenue	13.15	18.50	13.86	15.59
Cost of Operating Revenue	10.57	15.63	11.52	12.18
Gross Profit	2.59	2.86	2.34	3.40
Gross Margin	19.7	15.5	16.9	21.8
Total Operating Expenses	12.80	18.00	13.44	-
Operating Profit	0.36	0.49	0.42	-
Operating Margin	2.7	2.7	3.0	-
Financing Income/(Expense) - Net	-0.06	-0.05	0.03	-0.01
Profit before Taxes	0.33	0.45	0.52	0.95
Income Taxes	0.05	0.17	0.12	0.25
Profit after Tax	0.28	0.28	0.41	-
PAT Margin	2.1	1.5	2.9	-
EPS - Basic - ex Extraordinary Items	0.63	0.62	0.91	-
EPS - Diluted - ex Extraordinary Items	0.63	0.62	0.91	-
EBIT	0.36	0.49	0.42	0.80
EBITDA	0.43	0.58	0.52	0.94
EBITDA Margin	3.3	3.1	3.7	6.0

Balance Sheet

Abridged

Understanding Balance Sheet

Unjha Formulations Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR
Total Current Assets	2.31	3.81	3.35	4.21
Property Plant & Equipment - Net	0.60	0.62	0.70	0.80
Total Non-Current Assets	1.10	1.12	1.20	1.30
Total Assets	3.41	4.93	4.56	5.51
Total Current Liabilities	0.96	2.20	1.41	1.67
Total Non-Current Liabilities	-	0.01	0.00	-
Total Liabilities	0.96	2.20	1.42	1.67
Total Shareholders' Equity	2.45	2.73	3.14	3.84
Total Equity	2.45	2.73	3.14	3.84
Total Liabilities & Equity	3.41	4.93	4.56	5.51

Cash Flow

Abridged

Understanding Cash Flow Statement

Unjha Formulations Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	0.42	0.58	0.59	0.00
Working Capital - Increase/(Decrease)	-0.73	0.39	-0.64	1.24
Net CF from Operating Activities	-0.31	0.97	-0.05	1.24
Capital Expenditures - Net	0.10	0.11	0.18	0.23
Net CF from Investing Activities	-0.10	-0.11	-0.18	-0.23
Net Cash Flow from Financing Activities	-	-	-	-
Free Cash Flow to Equity	-0.42	0.86	-0.23	1.00
Free Operating CF net dividend	-0.42	0.86	-0.23	1.00
Free Operating CF	-0.42	0.86	-0.23	1.00

Business Segment Analysis

Unjha Formulations Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Unjha Formulations Ltd.

Regional Segment Analysis

Unjha Formulations Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Unjha Formulations Ltd.

Historical Segment Analysis

Track how Unjha Formulations Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Unjha Formulations Ltd.

Frequently Asked Questions

What is the revenue of Unjha Formulations Ltd.?

The latest trailing twelve month revenue of Unjha Formulations Ltd. is ₹ 15.59 Cr, reflecting a 1-year growth of 12.43% and a 3-year CAGR of 5.82%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Unjha Formulations Ltd.?

The latest trailing twelve month net profit (PAT) of Unjha Formulations Ltd. is ₹ 0.70 Cr, with a 3-year earnings CAGR of 35.62%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Unjha Formulations Ltd.?

The operating margin of Unjha Formulations Ltd. is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of Unjha Formulations Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Unjha Formulations Ltd. is 1.57. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Unjha Formulations Ltd.?

The debt-to-equity ratio of Unjha Formulations Ltd. stands at 0.00. The interest coverage ratio is 101.03x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Unjha Formulations Ltd.?

The estimated book value per share of Unjha Formulations Ltd. is 8.58 (derived from a P/B ratio of 2.78 and market price of ₹ 23.81), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Unjha Formulations Ltd.?

The trailing twelve month operating cash flow of Unjha Formulations Ltd. is ₹ 1.24 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Unjha Formulations Ltd. report consolidated or standalone financials?

Unjha Formulations Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.